Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: ciprofloxacin er attending: chief complaint: abdominal pain and fever major surgical or invasive procedure: pancreatic pseudocyst gastrostomy . history of present illness: 52 yo f with a past medical history of crohn's disease and recent post-ercp pancreatitis c/ pseudocyst formation was transferred to the from an osh with abdominal pain and fevers to 102. the pt was previously admitted to from with post-ercp pancreatitis complicated by pancreatic necrosis and pseudocyst formation. her course was complicated by c. diff associated diarrhea, and she was discharged on po flagyl and po vancomycin as well as tpn with a small amount of po intake. the patient presented to hospital on with persistent abdominal pain, fevers, and shortness of breath. broad spectrum antiobiotics were started for presumptive infected pancreatic necrosis. she underwent a ct scan which demonstrated persistent pancreatic collections. she continued to spike fevers to 102 and experience respiratory decompensation requiring icu care at hospital. she was transferred to sicu for further management. past medical history: pmh: - ercp pancreatitis with estimated 50% pancreatic necrosis - restless leg syndrome - crohns disease - b/l ovarian cancer s/p tah/sbo and chemotherapy - gerd psh: - s/p cholecystectomy - s/p appendectomy - s/p tah/bso (chemotherapy) - s/p l nephrectomy for ovarian metastases social history: no cigarettes; occasional alcohol. she does not drink coffee. lives with husband; retired from the va where she worked as a nursing assistant family history: father died of ca of the esophagus. three healthy siblings. physical exam: on admission: . temp 102.6 hr 107 bp 130/62 95%5l general: nad, ill-appearing; alert and responsive. heent: sclerae anicteric. mucous membranes moist,intact. heart: tachycardic, no murmurs appreciated. lungs: diminished breath sounds at bases; faint crackles at bases abdomen: well-healed ruq and vertical midline scars present. soft, distended, diffusely tender to palpation without guarding or peritoneal signs. extrem: no peripheral edema. . on discharge: t 98.7 hr 88 bp 121/76 rr 18 96%ra general: nad, aox3 heent: no scleral icterus. heart: rrr, no mrg lungs: cta bilaterally abd: soft, nontender, nondistended extremities: no cyanosis, clubbing or edema pertinent results: 05:52pm urine blood-lg nitrite-neg protein-30 glucose-neg ketone-tr bilirubin-neg urobilngn-0.2 ph-6.5 leuk-mod 05:52pm urine rbc-* wbc- bacteria-mod yeast-few epi- 04:45pm glucose-135* urea n-15 creat-0.7 sodium-129* potassium-3.8 chloride-93* total co2-29 anion gap-11 04:45pm alt(sgpt)-20 ast(sgot)-30 ld(ldh)-297* alk phos-135* amylase-447* tot bili-0.2 dir bili-0.1 indir bil-0.1 04:45pm lipase-114* 04:45pm albumin-2.5* calcium-7.8* phosphate-2.8 magnesium-1.7 04:45pm wbc-14.8* rbc-2.72* hgb-7.7* hct-24.0* mcv-88 mch-28.4 mchc-32.2 rdw-14.6 04:45pm neuts-92.2* lymphs-4.4* monos-2.2 eos-0.9 basos-0.2 04:45pm plt count-532* 04:45pm pt-16.5* ptt-31.2 inr(pt)-1.5* . ct abd/pelvic w/contrast & cta w & w/o contrast & recon: 1. no evidence for pulmonary embolus or acute aortic syndrome, although evaluation of the subsegmental pulmonary arteries is limited by suboptimal contrast bolus timing. 2. small bilateral pleural effusions, with adjacent bibasilar consolidation, which could reflect an element of atelectasis, although pneumonia is not excluded. additional area of ground-glass opacity with nodular center is seen at the right apex. this could represent infection or pulmonary infarct. however, malignancy such as bronchoalveolar cell carcinoma is not excluded, and followup to resolution is recommended. 3. large pancreatic pseudocyst within the pancreatic bed. there is minimal residual normal pancreatic tissue identified. 4. new fluid collection within the right mid abdomen, inferior to the tip of the liver. 5. status post left nephrectomy. 6. thickening and fibrofatty proliferation involving the terminal ileum. these changes are consistent with chronic crohn's disease. there may also be inflammatory changes involving the sigmoid colon/rectum. . cta chest w&w/o c&recons, non-coronary: 1. no pulmonary embolism. 2. interval progression of moderate bilateral pleural effusion. unchanged moderate bibasilar atelectasis. 3. new foci of ground-glass opacities in the prebronchovascular distribution and new foci of consolidation within both lung apices. the differential diagnoses include infectious and inflammatory etiologies. . ct abdomen w/contrast: 1. interval decrease in size of the large pancreatic pseudocyst within the pancreatic bed and interval decrease in the size of pseudocyst located in the right upper quadrant area. 2. new fluid accumulation anterior to the body of the stomach. it is unclear if this might be post-surgical in nature, status post cyst gastrotomy. 3. no vascular compromise is noted including no pseudoaneurysm and no vascular thrombosis. 4. new mild right hydrouretronephrosis, unclear consequence. heterogeneous enhancement of the right kidney could be seen in setting of pyelonephritis; please correlate with urinalysis/urine culture. this was called to dr. at 4:30pm, . 5. slight interval increase in the left pleural effusion and slight interval improvement in bibasal atelectasis. . ct abdomen/pelvis w/contrast: 1. interval decrease in the size of large pancreatic pseudocyst within the pancreatic bed and interval decrease in the size of pseudocyst located in the right upper quadrant area. no new focus of fluid collection is noted. 2. no vascular compromise is noted including no pseudoaneurysm and no thrombosis. 3. slight decrease in the bibasilar atelectasis. 4. unchanged small left pleural effusion. . pa cxr: interval removal of a right-sided catheter. progressed left pleural effusion and associated opacities, likely atelectasis. brief hospital course: the patient was transferred from the icu at in to sicu with fevers, abdominal pain and respiratory decompensation for further evaluation and management. the patient was npo with a foley catheter, piv, and ricc line in place. an a-line and cvl were placed. present picc line discontinued; tip sent for culture. infectious disease consulted upon admission. pancultures repeated. iv antibiotics continued/updated. the patient was hemodynamically stable. : admitted to sicu, cvl and a-line placed, 1 unit prbc, no pe : started micafungin, echo, restarted tpn : triggered for tachy 180s after albuterol treatment; given lopressor 5mg x3 doses, discontinued albuterol nebs, and switched to xopenex nebs with resultant normalization of heart rate. : to or for cyst-gastrostomy, admitted to sicu thereafter : self-extubated, tpn restarted, kvo, micafungin changed to fluconazole : triggered on floor with desats, transferred to sicu, ct chest, intubated, a-line placed : ip consulted for (l) pleural effusion; declined tap, lasix 20mg x1 : vanco trough 30, so evening dose held, recruitment maneuvers, bronchoscopy secretions without plug, attempted vent wean, but failed t-piece, cr 1.2 (1.1), fena=1.2, d/c'd zosyn switched to levaquin, 5% albumin x1, lasix held, urine eos neg, peep incr 7 (5) : failed sbt, back on vent , held vanco/decreased dose, fena not c/w prerenal, lasix, diuresis -2l : urine greenish sediment, discontinued po&iv vancomycin, discontinued levaquin, tee, extubated, sips : discontinued ngt, npo, discontinued (l) scl cvl, placed (r) scl cvl, increased fluconazole to 600, ct abdomen : started on sips, continued on transferred to floor. : diet advanced to clears with good tolerability, iv fluid rate decreased to 25ml/hr, foley discontinued, tpn continued : diet advanced to fulls with good tolerability, iv fluids discontinued, continued on tpn : beta-glucan sent, ambulated frequently : chest/abdominal ct performed, tolerated fulls, continued on tpn : made npo for tee performed today - no endocarditis, diet then advanced to lactose-restricted regular with boost supplement, reglan started : calorie counts started. several fevers greater than 101; cvl discontinued with tip sent for culture. : tpn discontinued. cvl tip positive for gpcs. iv vancomycin added to flagyl and fluconazole. : continued with fever 102; daily blood cultures started. : continued with fever greater than 101. daily blood cultures continued. received 1 unit prbc for hct 23.7 with post-transfusion increase to 26.1. flagyl discontinued. : continued with fever greater than 101. daily blood cultures continued. abdominal/pelvic ct with contrast revealed interval decrease in size of pseudocyts without new fluid collections. : temperature decreased. continued on antibiotics. tolerating diet. stool for c.diff sent. : triggered for svt with heart rate 170-180; cxr, ekg, enzymes, and labwork performed. cardiology was consulted. treated with iv lopressor x3 followed by adenosine 6mg iv single dose with return to sr. continued on low dose lopressor. remained hemodynamically stable. no further episodes during hospitalization. : follow-up ekg with nsr. patient stable. no events. : tolerating diabetic, lactose-free diet. remained stable from cardiac standpoint. glucose monitoring/insulin administration teaching underway; following. : vancomycin discontinued; continued on po fluconazole. hemodynamically stable. at the time of discharge on , the patient was doing well, afebrile with stable vital signs. the patient was tolerating a regular lactose-free, diabetic diet, ambulating, voiding without assistance, and pain was well controlled. she will be discharged home with services and home physical therapy. the patient received discharge teaching and follow-up instructions with understanding verbalized and agreement with the discharge plan. medications on admission: lomotil, requip 1mg qhs, zoldipem 5mg po qhs prn, omeprazole 20mg po daily. discharge medications: 1. ropinirole 1 mg tablet sig: one (1) tablet po qpm (once a day (in the evening)). 2. hydromorphone 2 mg tablet sig: 1-2 tablets po q3-4hours as needed for pain. disp:*30 tablet(s)* refills:*0* 3. acetaminophen 325 mg tablet sig: 1-2 tablets po q6h (every 6 hours) as needed for fever or pain. 4. famotidine 20 mg tablet sig: one (1) tablet po q12h (every 12 hours). disp:*60 tablet(s)* refills:*2* 5. albuterol sulfate 90 mcg/actuation hfa aerosol inhaler sig: 1-2 puffs inhalation four times a day as needed for wheeze. disp:*1 hfa* refills:*2* 6. zolpidem 5 mg tablet sig: one (1) tablet po hs (at bedtime) as needed for insomnia. 7. amylase-lipase-protease 33,200-10,000- 37,500 unit capsule, delayed release(e.c.) sig: one (1) cap po tid w/meals (3 times a day with meals). disp:*100 cap(s)* refills:*2* 8. metoprolol tartrate 25 mg tablet sig: 1.5 tablets po tid (3 times a day). disp:*135 tablet(s)* refills:*2* 9. fluconazole 200 mg tablet sig: two (2) tablet po q24h (every 24 hours): thru . disp:*40 tablet(s)* refills:*0* 10. insulin glargine 100 unit/ml solution sig: fifteen (15) units subcutaneous at bedtime. disp:*1 vial* refills:*2* 11. metoclopramide 10 mg tablet sig: one (1) tablet po qid (4 times a day). disp:*120 tablet(s)* refills:*2* 12. acetaminophen 325 mg tablet sig: 1-2 tablets po q6h (every 6 hours) as needed for pain/fever. 13. humalog 100 unit/ml solution sig: 1-7 units subcutaneous as directed per the humalog insulin sliding scale. disp:*1 vial* refills:*2* 14. insulin syringe-needle u-100 1 ml 30 x syringe sig: one (1) syringe per injection miscellaneous as directed. disp:*1 box* refills:*2* 15. lancets,ultra thin misc sig: one (1) lancet miscellaneous as directed. disp:*1 box* refills:*0* 16. alcohol pads pads, medicated sig: one (1) pad topical as directed. disp:*1 box* refills:*0* 17. one touch ultra test strip sig: one (1) strip in as directed qid. disp:*100 strips* refills:*0* discharge disposition: home with service facility: of southeastern mass. discharge diagnosis: 1. pancreatic pseudocyst. 2. fungemia. 3. type 2 diabtes mellitus 4. single episode svt discharge condition: stable. discharge instructions: please call your doctor or nurse practitioner or return to the emergency department for any of the following: *you experience new chest pain, pressure, squeezing or tightness. *new or worsening cough, shortness of breath, or wheeze. *if you are vomiting and cannot keep down fluids or your medications. *you are getting dehydrated due to continued vomiting, diarrhea, or other reasons. signs of dehydration include dry mouth, rapid heartbeat, or feeling dizzy or faint when standing. *you see blood or dark/black material when you vomit or have a bowel movement. *you experience burning when you urinate, have blood in your urine, or experience a discharge. *your pain in not improving within 8-12 hours or is not gone within 24 hours. call or return immediately if your pain is getting worse or changes location or moving to your chest or back. *you have shaking chills, or fever greater than 101.5 degrees fahrenheit or 38 degrees celsius. *any change in your symptoms, or any new symptoms that concern you. please resume all regular home medications , unless specifically advised not to take a particular medication. also, please take any new medications as prescribed. please get plenty of rest, continue to ambulate several times per day, and drink adequate amounts of fluids. avoid lifting weights greater than lbs until you follow-up with your surgeon. avoid driving or operating heavy machinery while taking pain medications. incision care: *please call your doctor or nurse practitioner if you have increased pain, swelling, redness, or drainage from the incision site. *avoid swimming and baths until your follow-up appointment. *you may shower, and wash surgical incisions with a mild soap and warm water. gently pat the area dry. *if you have staples, they will be removed at your follow-up appointment. *if you have steri-strips, they will fall off on their own. please remove any remaining strips 7-10 days after surgery. followup instructions: provider: , md (covering for dr. phone: date/time: 11:15; location: 3, . please call ( to schedule a follow-up appointment with dr. (pcp) in weeks. follow-up issues: diabetes/insulin management, single episode svt while hospitalized started on low dose lopressor, standard post-operative follow-up. procedure: venous catheterization, not elsewhere classified continuous invasive mechanical ventilation for 96 consecutive hours or more parenteral infusion of concentrated nutritional substances diagnostic ultrasound of heart insertion of endotracheal tube other bronchoscopy arterial catheterization presacral sympathectomy internal drainage of pancreatic cyst diagnoses: esophageal reflux unspecified pleural effusion diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled cardiac complications, not elsewhere classified pulmonary collapse regional enteritis of unspecified site other respiratory complications other and unspecified infection due to central venous catheter cyst and pseudocyst of pancreas other and unspecified mycoses restless legs syndrome (rls) personal history of malignant neoplasm of ovary 

Answer: The patient is high likely exposed to